nybomycin has been researched along with isoniazid in 1 studies
*Isoniazid: Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. [MeSH]
*Isoniazid: Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. [MeSH]
| Studies (nybomycin) | Trials (nybomycin) | Recent Studies (post-2010) (nybomycin) | Studies (isoniazid) | Trials (isoniazid) | Recent Studies (post-2010) (isoniazid) |
|---|---|---|---|---|---|
| 12 | 0 | 7 | 21,815 | 960 | 4,493 |
| Protein | Taxonomy | nybomycin (IC50) | isoniazid (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 4.85 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 8.29 | |
| Putative FAD-containing monooxygenase MymA | Mycobacterium tuberculosis H37Rv | 4.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, M; Han, C; Joubert, JP; Kamiya, K; Kobayashi, M; Kotoku, N; Moodley, P; Pruksakorn, P; Shin, D; Sumii, Y | 1 |
1 other study(ies) available for nybomycin and isoniazid
| Article | Year |
|---|---|
Anti-dormant mycobacterial activity and target analysis of nybomycin produced by a marine-derived Streptomyces sp.
Topics: Antitubercular Agents; Aquatic Organisms; Cell Culture Techniques; Cosmids; DNA, Bacterial; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium bovis; Mycobacterium smegmatis; Mycobacterium tuberculosis; Quinolones; Streptomyces | 2015 |